SCHEMBL3417323

SCHEMBL3417323

O=C(O)c1ccc(Oc2ccc(-c3ccc(Oc4cccc(C(=O)O)c4C(=O)O)cc3)cc2)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.54
GALK1 P51570 1/20 0.54
CASP6 P55212 1/20 0.54
MCL1 Q07820 1/20 0.54
PLEC Q15149 1/20 0.54
POLB P06746 3/20 0.54
HPSE Q9Y251 1/20 0.50
PYGL P06737 7/20 0.48
KDM4E B2RXH2 1/20 0.46
PYGM P11217 8/20 0.46
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MITF O75030 1/20 0.41
MAPK1 P28482 1/20 0.41
GFER P55789 1/20 0.41
DUSP3 P51452 1/20 0.41
PTPN5 P54829 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422032 0.96 POLB (0.57) TDP1GALK1CASP6MCL1PLEC
SCHEMBL29404149 0.93 PYGL (0.53) TDP1GALK1CASP6MCL1PLEC
SCHEMBL716921 0.93 PYGL (0.53) TDP1GALK1CASP6MCL1PLEC
SCHEMBL4100316 0.90 CTNNB1 (0.46) TDP1GALK1CASP6MCL1PLEC
SCHEMBL425842 0.89 POLB (0.70) TDP1GALK1CASP6MCL1PLEC
SCHEMBL420308 0.88 POLB (0.50) TDP1GALK1CASP6MCL1PLEC
SCHEMBL421351 0.87 POLB (0.59) TDP1GALK1CASP6MCL1PLEC
SCHEMBL29658106 0.87 CTNNB1 (0.49) TDP1POLBKDM4ELMNAALDH1A1
SCHEMBL425841 0.87 CTNNB1 (0.49) TDP1POLBKDM4ELMNAALDH1A1
SCHEMBL1044631 0.86 HPSE (0.48) TDP1GALK1CASP6MCL1PLEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640275-B1 CURABLE EPOXY COMPOSITIONS AND CURED PRODUCTS THEREOF SHPP GLOBAL TECH BV (NL) 2022-06-29 EP disclosed
US-20220162386-A1 METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE COMPOSITION, AND POLY(ETHERIMIDES) DERIVED FROM THE BIPHENOL DIANHYDRIDE SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2022-05-26 US disclosed
US-20220073483-A1 METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE, AND POLY(ETHERIMIDE)S DERIVED FROM THE BIPHENOL DIANHYDRIDE SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2022-03-10 US disclosed
EP-3484682-B1 METHOD OF MAKING AN EXTRUDED THIN FILM, AND THIN FILM SO PRODUCED SHPP GLOBAL TECH BV (NL) 2021-10-27 EP disclosed
WO-2020160201-A1 METHOD FOR PURIFICATION OF A BIPHENOL TETRAACID COMPOSITION AND A BIPHENOL TETRAACID COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-08-06 WO disclosed
WO-2020160115-A1 METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE, AND POLY(ETHERIMIDE)S DERIVED FROM THE BIPHENOL DIANHYDRIDE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-08-06 WO disclosed
EP-3640275-A1 CURABLE EPOXY COMPOSITIONS AND CURED PRODUCTS THEREOF SABIC Global Technologies B.V. (NL) 2020-04-22 EP disclosed
EP-3560978-A1 HIGH HEAT THERMOSET EPOXY COMPOSITIONS SABIC Global Technologies B.V. (NL) 2019-10-30 EP disclosed
EP-3262123-B1 ELECTRICAL TRACKING RESISTANCE COMPOSITIONS, ARTICLES FORMED THEREFROM, AND METHODS OF MANUFACTURE THEREOF SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-04-17 EP disclosed
EP-3298081-A1 IMPROVED DIELECTRIC STRENGTH COMPOSITIONS SABIC Global Technologies B.V. (NL) 2018-03-28 EP disclosed
EP-1654740-A1 ELECTRICALLY CONDUCTIVE COMPOSITIONS COMPRISING CARBON NANOTUBES AND METHOD OF MANUFACTURE THEREOF GENERAL ELECTRIC COMPANY (US) 2006-05-10 EP disclosed
WO-2006012250-A1 MISCIBLE POLYIMIDE BLENDS GENERAL ELECTRIC COMPANY (US) 2006-02-02 WO disclosed
WO-2005044865-A2 ELECTRICALLY CONDUCTIVE COMPOSITIONS AND METHOD OF MANUFACTURE THEREOF GENERAL ELECTRIC COMPANY (US) 2005-05-19 WO disclosed
WO-2005034144-A1 CONDUCTIVE THERMOPLASTIC COMPOSITIONS, METHODS OF MANUFACTURE AND ARTICLES DERIVED FROM SUCH COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 2005-04-14 WO disclosed
WO-2005015574-A1 ELECTRICALLY CONDUCTIVE COMPOSITIONS COMPRISING CARBON NANOTUBES AND METHOD OF MANUFACTURE THEREOF GENERAL ELECTRIC COMPANY (US) 2005-02-17 WO disclosed
EP-1381503-A1 METHODS FOR EMBOSSING AND EMBOSSED ARTICLES FORMED THEREBY GENERAL ELECTRIC COMPANY (US) 2004-01-21 EP disclosed
WO-2002085605-A1 METHODS FOR EMBOSSING AND EMBOSSED ARTICLES FORMED THEREBY GENERAL ELECTRIC COMPANY (US) 2002-10-31 WO disclosed
US-4910289-A Crystal structure; blend with poly(arylene sulfide) AMOCO CORPORATION (US) 1990-03-20 US disclosed
EP-0331493-A2 Medical devices made from poly(etherimides) AMOCO CORPORATION (US) 1989-09-06 EP disclosed
EP-0158733-A1 Polyestercarbonate/polyetherimide blends GENERAL ELECTRIC COMPANY (US) 1985-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162386-A1 METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE COMPOSITION, AND POLY(ETHERIMIDES) DERIVED FROM THE BIPHENOL DIANHYDRIDE CA3, FHIT, PPIP5K2 TDP1 3556/4885GALK1 2451/4885CASP6 4833/4885
US-20220073483-A1 METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE, AND POLY(ETHERIMIDE)S DERIVED FROM THE BIPHENOL DIANHYDRIDE CA3, FHIT, PUF60 TDP1 4215/4885GALK1 4212/4885CASP6 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.